Multicentre cross over study of aminoglutethimide and trilostane in advanced postmenopausal breast cancer.

Trilostane and Aminoglutethimide, each given with a physiological replacement dose of hydrocortisone, were randomly allocated to 72 eligible postmenopausal advanced breast cancer patients; following treatment failure on either drug the patient continued with the other drug, if in a suitable clinical...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Williams, C. J., Barley, V. L., Blackledge, G. R., Rowland, C. G., Tyrrell, C. J.
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 1993
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1968660/
https://ncbi.nlm.nih.gov/pubmed/8260375
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki